Chronic heart failure in heart transplant recipients: Presenting features and outcome

Pierre Ambrosi1, Bernard Kreitmann2, Alberto Riberi2

  • 1Department of cardiology, La Timone hospital, Aix-Marseille university, rue Saint-Pierre, 13385 Marseille, France.

Insights

Heart failure after heart transplantation is linked to pre-existing conditions and acute rejection. Patients face high mortality, dialysis needs, and ascites, even with preserved heart function.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Heart Failure Research

Background:

  • Ageing heart grafts often develop coronary lesions and restrictive physiology.
  • Chronic heart failure (CHF) is a significant concern in long-term heart transplant recipients.
  • Understanding CHF in this population is crucial for improving patient outcomes.

Purpose of the Study:

  • To identify the presenting characteristics of chronic heart failure in heart transplant recipients.
  • To determine the long-term outcomes for heart transplant recipients who develop chronic heart failure.
  • To compare patients with and without heart failure post-transplantation.

Main Methods:

  • A cohort study comparing 44 heart transplant recipients with CHF (onset >1 year post-transplant) to 44 controls without CHF.
  • Analysis of pre-transplant medical history, including hypertension and diabetes.
  • Assessment of acute rejection episodes (grade ≥2R) within 12 months post-transplantation.

Main Results:

  • Patients developing CHF had higher rates of pre-transplant hypertension/diabetes and moderate-to-severe acute rejection.
  • At diagnosis, 50% had preserved systolic function and 36% had normal/near-normal coronary angiography.
  • CHF patients experienced significantly higher rates of ascites (10/44) and end-stage renal failure requiring dialysis (18/44), with 50% mortality within 2 years.

Conclusions:

  • Heart failure in heart transplant recipients often presents with preserved systolic function and variable coronary findings.
  • Key outcomes include high mortality post-diagnosis, frequent need for renal dialysis, and ascites.
  • Early identification and management strategies are vital for this high-risk group.
Abstract

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.2K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
679
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
533
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
825